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1. Introduction 
The incidence of abdominal aortic aneurysm (AAA) ranges from 
2 to 3% in the general population with an increasing incidence 
of 4–9% in men over the age of 60 reported [1,2]. The pathogen-
esis of AAA remains obscure and the treatment is still mechan-
ical. Studies of human aortic aneurysm tissue obtained at sur-
gery are informative but likely reflect the end stage of the dis-
ease process. To investigate the cause of aneurysmal disease and 
to determine early pathophysiological changes in AAA, animal 
models are commonly used. Studies with animal models have 
led to advances including recognition that chronic inflamma-
tion, increased expression of endogenous proteinases, degrada-
tion of structural matrix proteins, and medial smooth muscle 
cell depletion all play a role in the process of aneurysm develop-
ment [3,4]. Genetically engineered mice have been increasingly 
used to investigate the molecular mechanisms of AAA. Impor-
tant insights pertaining to inflammatory cytokines and matrix 
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Abstract 
Objective: Evidence has demonstrated profound influence of genetic background on cardiovascular phenotypes. Murine 
models in Marfan syndrome (MFS) have shown that genetic background-related variations affect thoracic aortic aneu-
rysm formation, rupture, and lifespan of mice. MFS mice with C57Bl/6 genetic background are less susceptible to 
aneurysm formation compared to the 129/SvEv genetic background. In this study, we hypothesize that susceptibility 
to abdominal aortic aneurysm (AAA) will be increased in 129/SvEv mice versus C57Bl/6 mice. We tested this hypoth-
esis by assessing differences in aneurysm size, tissue properties, immune response, and MMP expression. 
Methods: Mice of C57Bl/6 or 129/SvEv background underwent AAA induction by periaortic application of CaCl2. Base-
line aortic diameters, tissue properties and MMP levels were measured. After aneurysm induction, diameters, MMP 
expression, and immune response (macrophage infiltration and bone marrow transplantation) were measured. 
Results: Aneurysms were larger in 129/SvEv mice than C57Bl/6 mice (83.0% ± 13.6 increase compared to 57.8% ± 6.4). 
The aorta was stiffer in the 129/SvEv mice compared to C57Bl/6 mice (952.5 kPa ± 93.6 versus 621.4 kPa ± 84.2). 
Baseline MMP-2 and post-aneurysm MMP-2 and -9 levels were higher in 129/ SvEv aortas compared to C57Bl/6 aor-
tas. Elastic lamella disruption/fragmentation and macrophage infiltration were increased in 129/SvEv mice. Myelog-
enous cell reversal by bone marrow transplantation did not affect aneurysm size. 
Conclusions: These data demonstrate that 129/SvEv mice are more susceptible to AAA compared to C57Bl/6 mice. 
Intrinsic properties of the aorta between the two strains of mice, including baseline expression of MMP-2, influence 
susceptibility to AAA. 
Keywords: Aneurysm, Matrix metalloproteinase, Aorta 
Abbreviations: AAA = abdominal aortic aneurysm; MFS = Marfan syndrome; MMP = matrix metalloproteinase;  
VVG = Verhoeff-Van Gieson  
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metalloproteinases (MMPs) have been obtained from mouse stud-
ies involving targeted disruptions of genes such as interferon-
g, tumor necrosis factor-a, MMP-2 and -9 [5–8]. Abundant evi-
dence has demonstrated the profound influence of genetic back-
ground on cardiovascular phenotypes [9–12]. Although a sin-
gle gene mutation has not been found in association with most 
AAAs, a positive family history of AAA in a first degree relative 
is known to increase the risk of aortic aneurysm by up to a factor 
of ten [13]. Attempts to define the genetic component(s) under-
lying AAA have used a variety of strategies, including both link-
age analysis and candidate gene approaches [14]; nonetheless, 
a consensus on the patterns of inheritance or specific linkages 
associated with AAA has yet to emerge. 
A variety of different mouse strains have been used to assess 
aortic aneurysms [15–19]. The most widely used parent strains 
for the production of mutants in aneurysm research are C57Bl/6 
and 129/SvEv mice [7,8,20]. In contrast to AAA, thoracic aortic 
aneurysms are associated with a number of known genetic muta-
tions. Marfan syndrome (MFS) is caused by fibrillin-1 gene muta-
tions that are responsible for thoracic aneurysm development 
[21]. Studies of animal models of MFS have shown that genetic 
background-related variations, C57Bl/6 or 129/SvEv, affect aneu-
rysm formation, rupture, and lifespan of mice [20,22]. The 129/
SvEv genetic background is associated with more rapid aneu-
rysm progression in MFS mice when compared to the C57Bl/6 
background [20]. As in AAA, higher MMP-2 expression in the 
aorta of Marfan syndrome mice plays an important role in aneu-
rysm formation [21]. Therefore, the variance of thoracic aneu-
rysm susceptibility in MFS could also be informative regard-
ing the underlying genetic susceptibility to AAA. In reviewing 
our previous studies, we noted that 129/SvEv mice also devel-
oped larger AAAs compared to C57Bl/6 mice in response to 
CaCl2-aneurysm induction [7]. Based on these observations, we 
hypothesized that the difference seen in aneurysm susceptibil-
ity between the two genetic backgrounds is related to intrinsic 
differences in smooth muscle cell MMP-2 or macrophage MMP-9 
expression [7]. 
2. Materials and methods 
2.1. Animal aneurysm model 
All procedures and animal studies were approved by the Uni-
versity of Nebraska Medical Center IACUC. The experimental 
groups consisted of 24 eight weeks-old male C57Bl/6 mice (The 
Jackson Laboratory, Bar Harbor, Maine) and 20 eight weeks-old 
male 129/SvEv mice (Taconic, Germantown, New York). Mice 
were anesthetized and underwent laparotomy. The abdominal 
aorta between the renal arteries and bifurcation of the iliac arter-
ies was isolated from the surrounding retroperitoneal structures. 
The diameter of the aorta was measured using a Leica Applica-
tion System (Leica Microsystems Inc, Buffalo Grove, IL). After 
baseline measurements, 0.25 M CaCl2 was applied to the aorta 
with care taken to avoid surrounding tissue. After 15 min the 
aortawas rinsed with 0.9% sterile saline, the laparotomy incision 
was closed, and mice were returned to their cages after recovery. 
Six weeks later the mice underwent repeat laparotomy, dissec-
tion, and measurement of the aorta. Aortic diameter was mea-
sured at the point of maximal dilatation. The aorta tissue was 
collected for zymographic and Western blot analyses. For his-
tological studies, the aorta was perfusion-fixed with 10% neu-
tral buffered formalin. NaCl (0.9%)was substituted for CaCl2 in 
sham controls. 
2.2. Isolation and infusion of myelogeous cells 
To evaluate the role of the myelogenous cells on aneurysm sus-
ceptibility, 6 week-old C57Bl/6 or 129/SvEv mice were irradiated 
(1200 rad) and transplanted with bone marrow from 129/SvEv 
(designated as C57bkg/SvEvbm mice) or C57Bl/6 mice (SvEvbkg/ 
C57bm mice), respectively. As controls, we also transplanted bone 
marrow from C57Bl/6 or 129/SvEv mice into the irradiated, same 
background mice, C57Bl/6 (designated as C57bkg/C57bm) or 129/ 
SvEv (SvEvbkg/SvEvbm), respectively. We have previously dem-
onstrated that this radiation protocol results in bone marrow 
ablation and is fatal without rescue by bone marrow transplan-
tation [23]. Bone marrow cell suspensions were prepared from 
the femurs of C57Bl/6 or 129/SvEv mice, and 5 _ 106 cells were 
infused via the lateral tail veins. Aneurysm induction followed 
1 week after bone marrow transplantation. 
2.3. Western blot analysis and gelatin zymography 
Aortic proteins were extracted as previously described [21]. The 
protein concentration of aortic tissues was standardized with a 
Bio- Rad protein assay. Equal amounts (10 mg) of aortic extracts 
were loaded under reducing conditions onto a 10% SDS-poly-
acrylamide gel and transferred to a polyvinylidene difluoride 
(PVDF) membrane (Amersham Biosciences, Piscataway, NJ). 
The membranes were then incubated with rabbit anti-tropoelas-
tin antibody (Elastin Products Company, Owensville, MO) or 
rabbit anti-collagen1a antibody (Cell Signaling, Danvers, MA). 
The bound primary antibody was detected with HRP-linked anti-
rabbit IgG (Cell Signaling). Immunoreactive bands were visu-
alized by autoradiography using ECL (Amersham Biosciences). 
Gelatin zymography for aortic tissue extracts was performed as 
described previously by Longo et al., with 0.8% gelatin in a 10% 
SDS-polyacrylamide gel [7]. The molecular sizes were determined 
using protein standards from Fermentas (Glen Burnie, MD). The 
intensity of each band was quantified by densitometry (Amer-
sham Biosciences). 
2.4. Microscopy 
1) Verhoeff-Van Gieson (VVG) connective tissue staining: After 
perfusion-fixation with 10% neutral-buffered formalin, mouse 
abdominal aortic tissues were embedded in paraffin and cut into 
4 mm sections. The slides were stained with Verhoeff’s solu-
tion, ferric chloride, sodium thiosulfate, and Van Gieson’s solu-
tion (Poly Scientific, Bay Shore, NY). Each staining cycle alter-
nated between fixing and washing procedures. The slides were 
examined and photographed using light microscopy (Nikon). 
2) Quantification of Elastin Disruption: Slides of both CaCl2-
treated C57Bl/6 and 129/ SvEv mice were examined under low 
power magnification. A semiquantitative analysis was used to 
estimate the percentage of the total circumference that demon-
strated elastin disruption. The analysis was performed by an 
observer blinded to mouse background. 3) Immunohistochemis-
try: Tissue sections on the slides were deparaffinized in xylene, 
rehydrated in ethanol, and rinsed in double-distilled water. The 
sections were incubated with a monoclonal rat anti-mouse Mac3 
antibody (PharMingen, San Diego, CA) diluted 1:500 for 30 min 
at 37 _C. The sections were then briefly washed in citrate solu-
tion and subsequently incubated with the secondary antibody, 
which is a mouse-absorbed, biotin-conjugated rabbit anti-rat IgG. 
Macrophage staining was examined using light microscopy. Sec-
tions incubated with secondary antibody only showed no posi-
tive staining. Three samples in each mouse strain were stained 
and evaluated. 
2.5. Elastic modulus measurement 
Quasi-static nanoindentation tests were performed on mouse aor-
tas using a commercial TriboScope nanoindenter with a light 
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microscope mounted (Hysitron, Minneapolis, MN). A nonporous 
conospherical fluid cell probe (TI-0077) with a radius of curva-
ture of R = 100 mmwas chosen. A custom-built sample holder 
was used to hold sample and ensure its hydration during inden-
tation test. The optical images obtained from the microscope will 
guide the movementt of the indenter and allow accurate control 
on the indentation positions. 
A trapezoidal load-hold-unload profile, which was composed 
of a linear loading portion of 2 s, a dwell portion of 20 s at a pre-
determined peak load and a linear unloading portion of 2 s, was 
used for each indentation. All samples were tested at peak load 
of 5 mN during the dwell period. In total,16 indentations in a 4 _ 
4 grid were conducted on each sample. The time interval between 
two indentations was 120 s. The distance between two indenta-
tion pointswas 200 mm. After indentations, the force-displace-
ment data were collected. The elastic moduli of the specimens 
were obtained by fitting the force-displacement data to the Oli-
ver-Pharr model. 
2.6. Elastase activity assay 
Elastase activity in the aortic extract (100 mg) from NaCl- and 
CaCl2-treated C57Bl/6 and 129/SvEv mice were measured using 
an elastase assay kit (AnaSpec, Fremont, CA) with and without 
10 mM EDTA according to manufacturer instructions. Neutro-
phil elastase gene expression in the aortic tissue of NaCl- and 
CaCl2-treated C57Bl/6 and 129/SvEv mice were examined by RT-
PCR as described previously [6]. 
2.7. Statistical analysis 
Measurements of aortic diameter, elastin levels, and elastic mod-
uli were expressed as mean value ± S.D. ANOVA was used to 
compare aortic diameters. Student’s t test was used to compare 
protein expression, MMP activity, and elastic moduli in different 
groups. Statistical significance was accepted at the P < .05 levels. 
3. Experimental results 
3.1. Aneurysm size and histology 
To test the hypothesis that genetic influences contribute to sus-
ceptibility of aneurysm formation, 129/SvEv and C57Bl/6 mice 
were subjected to CaCl2-aneurysm induction. Six weeks after 
periaortic application of CaCl2, 129/SvEv mice showed a larger 
increase in abdominal aortic diameter compared to C57Bl/6 
mice (Figure 1a, b–e and Table 1). The initial aortic diameter 
Figure 1. Aortic changes after 
NaCl and CaCl2 treatment in 
C57Bl/6 and 129/SvEv mice Aor-
tic diameters were measured 
before NaCl or CaCl2 incubation 
and at sacrifice. Aortic diame-
ter increases are shown in the 
bar graph (a). Bars represent the 
mean ± SD of at least 6 mice per 
group. The diameter in the CaCl2-
treated groups was increased 
significantly at sacrifice in both 
C57Bl/6 and 129/SvEv mice com-
pared to NaCl treated mice (*P < 
.01). The aortic dilatation in CaCl2-
treated 129/SvEv mice was sig-
nificantly greater compared to 
CaCl2-treated C57Bl/6 mice (#P 
< .05). Photographs (b–e) show 
the mouse aortas in C57Bl/6 
and 129/SvEv mice with the dot-
ted line indicating the outer bor-
der of the aortas before (b, c) 
and after (d, e) CaCl2 aneurysm 
induction, respectively, (n = 6–10/
group). VVG staining for elastic 
fibers (f–m). Aortic lamellae dis-
ruption (10× magnification) (h, i) 
and elastic fiber fragmentation 
(40× magnification) (l, m) were 
more severe in 129/SvEv (i, m) 
than in C57Bl/6 (h, l) mice (n = 
3–5/group). n, percentage of aor-
tic circumference showing elas-
tin disruption in CaCl2-treated 
C57Bl/6 and 129/SvEv mice (n = 3 
aortas/group).  
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between two strains was not significantly different. At baseline, 
VVG staining of aortic sections from C57Bl/6 and 129/SvEv mice 
showed no difference (Figure 1f, g, j, k) while both showed dis-
ruption and fragmentation of medial elastic lamellae after aneu-
rysm induction (Figure 1h, i, l, m). However, aortic elastic lamel-
lae degradation appeared to be more severe in 129/SvEv mice 
(Figure 1i and m) compared to C57Bl/6 mice (Figure 1h and l). 
These observations are consistent with the larger aneurysms 
that develop in the 129/SvEv mice. 
3.2. Aortic elastic moduli 
The elastic lamella, which is comprised of elastic fibers, colla-
gens, proteoglycans, and glycosaminoglycans, determines the bio-
mechanical properties of the aorta. To test the hypothesis that 
baseline aortic mechanical properties of C57Bl/6 mice differed 
from 129/SvEv mice, quasi-static nanoindentation tests were per-
formed on the aortas isolated from the two strains of mice. The 
elastic moduli of the specimens were obtained by fitting the for-
cedisplacement data to the Oliver-Pharr model. The elastic mod-
uli of C57Bl/6 mice were significantly less than that of the 129/
SvEv mice (Figure 2). Thus, the aortic wall in 129/SvEv mice was 
stiffer or less compliant than in the C57Bl/6 mice. 
3.3. Aortic tropoelastin content 
Matrix synthesis is known to accompany the matrix degrada-
tion seen in AAA. Production of tropoelastin, the precursor mol-
ecule that becomes incorporated into mature elastin fibers, in 
the aneurysmal aortas was examined by Western blot analy-
sis. At baseline, therewas no different in tropoelastin produc-
tion between two strains (Figure 3a). The tropoelastin levels in 
CaCl2-treated aortas of 129/SvEv mice were decreased by one 
third compared to CaCl2- treated aortas of C57Bl/6 mice (Figure 
3b). The procollagen 1a levels in the aortas were also examined 
byWestern blot analysis. There was no difference in procollagen 
1a content between the two strains of mice (data not shown). 
These data suggest that the 129/SvEv mice may be less able to 
repair elastin once it has been disrupted. 
Table 1. Changes in aortic diameter in C57Bl/6 and 129/SvEv mice 
after treatment of NaCl and CaCl2. 
Treatment  C57Bl/6   129/SvEv 
 NaCl  CaCl2  NaCl  CaCl2 
Number  8  16  6  12 
Pre-treatment (mm)  520 ± 14  507 ± 7  544 ± 15  550 ± 17 
Post-treatment (mm)  562 ± 17  797 ± 30*  628 ± 18  1067 ± 67*# 
AAA development (%)  0 56  0 83 
Percent increase (%)  8.3  57.8 1 5.9  96.3 
Aortic diameters were measured before NaCl or CaCl2 incubation (Pre) and at 
sacrifice (Post). Measurements of aortic diameter were expressed as mean 
± SE. The percent of increase was represented as a percent compared with 
pre-treatment. The development of aneurysm was defined as at least a 50% 
increase relative to original aortic diameter. *P < .01, Student’s t test, compared 
to pre-treatment; #P < .05 compared to CaCl2-treated C57Bl/6. 
Figure 2. Elastic modulus of aortic tissues from C57Bl/6 and 129/SvEv 
mice Prior to aneurysm induction, quasi-static nanoindentation tests 
were performed on the aortas and the elastic modulus was deter-
mined (n = 3 per group, *P < .05). 
Figure 3. Aortic tropoelastin 
content Western blot anal-
ysis was used to determine 
tropoelastin content from 
C57Bl/6 and 129/SvEv mice 
before (a) and after (b) AAA 
induction. Relative levels 
of tropoelastin content in 
mouse aortas were quanti-
fied as shown in bar graphs 
(*P < .05 compared to CaCl2-
treated C57Bl/6 mice) (n = 
5–7/group). 
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3.4. Aortic MMP-2 and MMP-9 expression 
MMP-2 and MMP-9 are essential for the connective tissue degra-
dation in the aortic wall leading to AAA [7]. Because the greater 
level of elastin degradation in the 129/SvEv mice suggests higher 
levels of MMP activity, we determined if the aortas from C57Bl/6 
and 129/SvEv mice expressed different levels of MMP-2 and 
MMP-9 at baseline and after aneurysm induction. Aortic pro-
tein was analyzed by gelatin zymography. As shown in Figure 4a, 
latent MMP-2 expression in untreated 129/SvEv mice was sig-
nificantly higher than in untreated C57Bl/6 mice. Furthermore, 
after aneurysm induction, active forms of MMP-2 and MMP-9 
were higher in the aortas of 129/SvEv mice (Figure 4b). These 
results demonstrated that 129/SvEv mice express higher lev-
els of pro- MMP-2 intrinsically. Additionally, after aortic injury, 
there is greater activation of MMP-2 and MMP-9 in 129/SvEv 
mice. Increased MMP-9 expression in aortic tissues after aneu-
rysm induction may indicate higher levels of MMP-9 expression 
from macrophages or increased macrophage infiltration into the 
aortic tissue in 129/SvEv mice compared to C57Bl/6 in response 
to CaCl2 treatment. Therefore, aortic tissues were examined for 
the presence of Mac3-positive macrophages. The images obtained 
suggested greater macrophage infiltration in the 129/SvEv mice 
aortas compared to C57Bl/6 mice (Figure 4c and Table 2). These 
results suggest intrinsic differences in mesenchymal cell MMP-2 
levels and also differences in response to injury. 
3.5. Aortic elastase activity 
In addition to MMP-2 and -9, other elastases could be responsi-
ble for the elastin degradation in AAA. We measured elastase 
activity in the aortic tissue from C57Bl/6 and 129/SvEv mice. 
Elastolytic activity was similar between NaCl-treated C57Bl/6 
and 129/ SvEv mice (Figure 5a). However, elastase activity in 
CaCl2-treated 129/ SvEv and C57Bl/6 mice was significantly 
higher than NaCl-treated 129/SvEv or C57Bl/6, respectively (Fig-
ure 5a). Furthermore, compared to CaCl2-treated C57Bl/6 mice, 
elastolytic activity in CaCl2-treated 129/SvEv was higher (Fig-
ure 5a). Neutrophils play an important role in aneurysm for-
mation [24,25]. We also tested neutrophil elastase gene expres-
sion using RT-PCR. We found that there were no significant 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Aortic MMP-2 and MMP-9 expression Gelatin zymography analysis of MMP activities expressed in the aortas of C57Bl/6 and 129/SvEv 
mice, a) Untreated controls; b) CaCl2- treated mice. Representative zymogram gels are shown in left panels. Relative levels of pro-MMP-9, MMP-9, 
pro-MMP-2, MMP-2 in mouse aortas were quantified and data shown in the bar graphs (*P < .05). c) Macrophages in aortic tissue were evaluated 
and scored with values from 0–3 as previously described (7). Zero indicates that there were no Mac3-positive cells, 3 indicated many Mac3-pos-
itive cells in a limited area, and 1 and 2 were used to classify intermediate grades of Mac3-positive cells (n = 3/group). Representative immuno-
peroxidase staining for macrophages of aneurysmal aortic tissues from C57Bl/6 and 129/SvEv mice. Mac3-positive cells are indicated by arrows. 
Table 2. The number of macrophages in the CaCl2-treated aorta of 
129/SvEv and C57Bl/6 mice. 
                                                     Mouse strain macrophages 
129/SvEv  2.3 ± 0.6* 
C57Bl/6  1.0 ± 0.5 
Macrophages in aorta were evaluated and scored with values from 0 to 3. Zero 
means no Mac3-positive cells and 3 means many cells in a limited area, the 
values 1 and 2 are used to classify intermediate grades of infiltration. The val-
ues reflect the mean ± SD. *P = .0390, Student’s t test. n = 3. 
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differences between C57Bl/6 and 129/ SvEv mice at baseline or 
in aneurysmal aortic tissue (Figure 5b and c). In order to deter-
mine the contribution of MMPs, EDTA was used to block MMP 
activity prior to measuring total elastolytic activity (Figure 5a). 
These data demonstrated that the majority of enhanced activity 
was due to increased elastin degradation by MMPs.  
3.6. Role of myelogenous cells in AAA susceptibility 
The known role of inflammatory cells in AAA and differences 
in the levels of active MMP-9 in the C57Bl/6 and the 129/SvEv 
mice suggested that there could be intrinsic differences in 
the myelogenous cells. In order to investigate this, C57Bl/6-
derived bone marrow cells were infused into irradiated 129/
SvEv (SvEvbkg/ C57bm) mice and 129/SvEv-derived bone mar-
rowcells were infused into irradiated C57Bl/6 (C57bkg/SvEvbm) 
mice. As controls, we also transplanted bone marrow from 
C57Bl/6 or 129/SvEv mice into the irradiated, same background 
mice, C57Bl/6 (C57bkg/C57bm) or 129/ SvEv (SvEvbkg/SvEvbm), 
respectively. The chimeric mice were subjected to CaCl2-aneu-
rysm induction. Six weeks after aneurysm induction, SvEvbkg/
C57bm developed larger aneurysms than the C57bkg/SvEvbm 
(Figure 6a). Aortic diameter in the SvEvbkg/C57bm increased 
by 85% ± 4, while the C57bkg/SvEvbm increased by 56% ± 6 
(Table 3). The aortic diameter changes in C57bkg/C57bm and 
SvEvbkg/ SvEvbm were similar to C57bkg/SvEvbm and SvEvbkg/
C57bm, respectively. Furthermore, the disruption of the elastic 
lamellae of the aortic wall of CaCl2-treated C57bkg/SvEvbm was 
less severe than the SvEvbkg/C57bm chimeric mice (Figure 6b). 
Aortic MMP-2 and MMP-9 levels in C57bkg/SvEvbm mice were 
lower than in SvEvbkg/C57bm mice while it is similar between 
C57bkg/C57bm and C57bkg/SvEvbm and between SvEvbkg/SvEvbm 
and SvEvbkg/C57bm (Figure 6c). The changes in aortic diameter 
in the chimeric mice were very similar in magnitude to the dif-
ferences noted when the background strains were compared. 
These data do not support the concept that differences in the 
white cell compartments account for differences in aneurysm 
susceptibility. 
Figure 6. The role of myelogenous cells in AAA susceptibility The chi-
meric mice, C57bkg/C57bm, SvEvbkg/SvEvbm, C57bkg/SvEvbm, and 
SvEvbkg/C57bm, were subjected to CaCl2 aneurysm induction. Aor-
tic diameter changes were shown in the bar graph (a) (*P < .01 com-
pared to NaCl control; #P < .05 C57bkg/SvEvbm vs. SvEvbkg/C57bm 
and C57bkg/C57bm vs. SvEvbkg/SvEvbm after CaCl2 treatment). Bars 
represent the mean ± SD of 6 mice per group. Representative VVG 
staining of elastic fibers after aneurysm induction (b). Gelatin zymog-
raphy of aortic MMP-2 and -9 levels in CaCl2-treated C57bkg/C57bm 
(lane 1), C57bkg/SvEvbm (lane 2), SvEvbkg/SvEvbm (lane 3), and 
SvEvbkg/C57bm (lane 4) (c).  
Figure 5. Aortic elastase activity and neutrophil elastase expression 
a) Elastase activity in aortic tissue extract from C57Bl/6 and 129/SvEv 
mice was measured, (*P < .05 compared to NaCl-treated control, #P 
< .05 compared to CaCl2-treated C57Bl/6 mice) (n = 3/group). EDTA 
was used to block MMP activity. b) The neutrophil elastase expression 
in the aortas of C57Bl/6 and 129/SvEv mice was examined by RTPCR; 
untreated controls (left panel) and CaCl2-treated mice (right panel). 
c) The levels of neutrophil elastase mRNA relative to GAPDH in the 
aorta were quantified; data shown in the bar graphs (n = 3/group). 
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4. Discussion 
The majority of genomic studies used to identify susceptibility 
pathways involved in disease pathologies have been performed in 
the mouse [26–28]. The mouse provides a suitable model for the 
study of human genetics because more than 95% of the genome is 
identical. The mouse genome is easy to manipulate allowing dis-
eases to be modeled in transgenic animals once the target genes 
have been determined. Mice are also easy to breed with a short 
generation time and a short lifespan allowing direct study of dis-
ease development. Abundant evidence, however, demonstrates 
the profound influence of genetic background on the course and 
severity of many diseases [29–31]. Strain variability has been 
shown to influence aneurysm formation, progression, and even 
lifespan in MFS mouse models. Lima et al. demonstrated the 
effect of genetic background on the severity of the MFS pheno-
type by backcrossing the mgΔ allele, in which fibrillin-1 expres-
sion is reduced to 10% of normal levels, in 129/SvEv and C57Bl/6 
mouse strains [20]. The 129/SvEv background was more suscep-
tible to aneurysm formation and earlier aortic rupture. Increased 
susceptibility to aneurysm formation in the 129/SvEv background 
when compared to the C57Bl/6 background was also present in 
the least severe model of MFS (Fbn1C1039G/+; 50% normal fibril-
lin-1 expression levels). Clearly, the genetic differences between 
the two strains are relevant to thoracic aortic aneurysm patho-
genesis. To determine whether the development of AAA is depen-
dent on mouse genetic background, we induced aneurysms in 
two widely used mouse strains, C57Bl/6 and 129/SvEv. Mice 
from both genetic backgrounds displayed increased aortic diam-
eters and developed aneurysms in response to CaCl2 induction, 
but the aneurysms formed in 129/SvEv mice were significantly 
larger compared to C57Bl/6 mice. Compared to our previous study 
[7], the difference in CaCl2-treated aortic diameter between two 
strains was bigger in the present study. In previous study, the 
aneurysms in the two strains were not induced concurrently. In 
the present study, the aneurysms in two strains were induced 
simultaneously with one operator.We believe this better repre-
sents the differences between the two strains. In NaCl-treated 
controls of 129/SvEv mice, the average increase in aortic diame-
ter was larger than previous reported [7]. In the present study, 
we have used a camera having higher resolution to define the aor-
tic borders. We believe this primarily reflects growth of the aorta 
between 7 and 14 weeks. Consistent with these differences in 
aneurysm size, aortic elastic lamellar disruption and degradation 
in 129/SvEv mice were more severe compared to C57Bl/6 mice. 
Age and gender are also important factors in aneurysm develop-
ment in patients with AAA. Mice of the same age and gender were 
used to exclude these as possible confounding factors. 
Our current results, based on determination of the elastic 
modulus, demonstrate that the abdominal aortas of 129/SvEv 
mice were stiffer at baseline than those of C57Bl/6 mice. There 
is indirect evidence that patients with AAAs may have a sys-
temic increase in arterial stiffness. Dijk et al. have shown that 
the carotid artery is stiffer in AAA patients compared to control 
patients without AAA [32]. In order to determine if the differ-
ences in mechanical properties were related to intrinsic differ-
ences in gene expression, we examined aortic elastin and colla-
gen precursor levels prior to aneurysm induction. C57Bl/6 and 
129/SvEv mice express similar levels of tropoelastin and pro-
collagen (data not shown). There is evidence that the elasticity 
of arterial wall may impact susceptibility to arterial diseases. 
Studies have shown that aortic elastin haploinsufficiency leads 
to high blood pressure and progressive aortic valve malforma-
tion [33,34]. We did not measure tail cuff blood pressure in the 
current study but other studies have demonstrated that 129/
SvEv mice have higher basal blood pressure than C57Bl/6 mice 
and 129/SvEv mice are more likely to develop hypertension and 
renal damage than C57Bl/6 mice in response to deoxycorticoste-
rone acetate [35,36]. These results could occur because of base-
line differences in mechanical properties or be the result of dif-
ferences in response to exogenous stimuli. Currently, the associa-
tion between hypertension and AAA remains unclear. It has been 
reported that in angiotensin II-infused ApoE_/_ mice, AAA forma-
tion is independent of blood pressure elevation [37–39]. We have 
previously demonstrated that there is an ongoing repair mecha-
nism in patients with AAA as evidenced by high levels of colla-
gen gene expression [40]. Six weeks after CaCl2-induction, tro-
poelastin levels in 129/SvEv mice were significantly lower than 
C57Bl/6 mice. Procollagen levels did not differ between the two 
strains after aneurysm induction (data not shown). Aneurysm 
susceptibility may be related to baseline differences in tissue 
properties. This difference would be exacerbated in the 129/SvEv 
because of the reduced ability to produce equivalent amounts of 
tropoelastin as is produced by C57Bl/6. 
Matrix metalloproteinases, especially MMP-2 and -9, play 
important roles in aneurysm formation. Interestingly, 129/SvEv 
mice intrinsically produce higher amounts of latent MMP-2 in 
the aorta compared to C57Bl/6 mice. This results in higher lev-
els of active MMP-2 in 129/SvEv after CaCl2-treatment com-
pared to C57Bl/6. MMP-2 is primarily a product of resident aortic 
smooth muscle cells and fibroblasts. Initial degradation of elas-
tin byMMP-2 may produce elastin fragments, which are known 
to induce monocyte chemotaxis [41,42]. This may account for 
the increased macrophage infiltrates seen in the aortas of 129/
SvEv mice compared to C57Bl/6 mice. Baseline levels of active 
and latent MMP-9 were similar between the two mouse strains. 
This is not unexpected since macrophages are the main source of 
MMP-9 in aneurysm tissue but are not present in normal aortic 
tissue [43]. Levels of both latent and active MMP-9 were higher 
in 129/SvEv aortas than in C57Bl/6 aortas in response to CaCl2-
Table 3. Changes in aortic diameter in chimeric mice after treatment of NaCl and CaCl2. 
Treatment  C57bkg/SvEvbm  SvEvbkg /C57
bm  C57bkg/C57bm  SvEv
bkg/SvEvbm 
 NaCl  CaCl2  NaCl  CaCl2  CaCl2  CaCl2 
Number  5  5  5  5  4  5 
Pre-treatment (mm)  505 ± 11  534 ± 12  509 ± 7  510 ± 28  502 ± 20  517 ± 23 
Post-treatment (mm)  540 ± 21  837 ± 48*  531 ± 6  945 ± 71*#  779 ± 48  960 ± 77Ɨ 
AAA development (%)  0  60  0  100  50  100 
Percent of increase (%)  7  57  4  85  55  86 
Aortic diameters were measured before NaCl (or CaCl2) incubation (Pre) and at sacrifice (Post). Measurements of aortic diameter were expressed as mean ± SD. 
The percent of increase was represented as a percent compared with pre-treatment. The development of aneurysm was defined as at least 50% increase rela-
tive to original diameter of aortic diameter. *P < .01, Student’s t test, compared to pre-treatment; #P < .05 compared to CaCl2-treated C57
bkg/SvEvbm; Ɨ P < .05 
compared to CaCl2-treated C57
bkg/C57bm.  
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treatment. In addition to MMP-2 and -9, other proteases such as 
MMP-12, MMP- 7, MT1-MMP, neutrophil elastase, and cysteine 
proteases may contribute to elastin degradation and aneurysm 
formation [23,24,44–46]. We tested neutrophil elastase expres-
sion in the mouse aorta and found no difference between the two 
mouse strains (Figure 5b). Using EDTA to block MMP activity, it 
is evident that the majority of the increased elastolytic activity 
is due to MMPs. These data suggest three possible mechanisms 
for the increased aneurysm susceptibility in 129/SvEv. First, the 
larger reservoir of latent MMP-2 could result in more elastin 
fragmentation with resultant recruitment of inflammatory cells 
to the aorta. Second, the differences in aneurysm sizes could be 
related to inherent differences in tissue mechanical properties. 
Finally, the myelogenous cells of the 129/SvEv may produce a 
more vigorous response to injury, greater elastin degradation, 
and aortic expansion. 
It is known that inflammatory infiltrates play a pivotal role 
in aneurysm formation [3,5,6,47]. We investigated whether the 
myelogenous cell differences between the two strains of mice con-
tribute to aneurysm susceptibility. Two chimeric mice were cre-
ated, C57bkg/SvEvbm mice, hematopoietic tissue ablated C57Bl/6 
mice transplanted with 129/SvEv mouse myelogenous cells, and 
SvEvbkg/C57bm mice, hematopoietic tissue ablated 129/SvEv 
mice transplanted with C57Bl/6 mouse bone marrow cells. Six 
weeks after CaCl2-aneurysm induction, both chimeric mice pro-
duced aneurysms. However, the aneurysm sizes and pathological 
changes were similar to mice of their genetic background. These 
results demonstrate that myelogenous cells are not responsible 
for the background specific differences in aneurysm size between 
the two mouse strains. Thus, the difference in aneurysm suscep-
tibility is related to tissue properties, MMP expression, or some 
combination of both. 
A genetic predisposition to AAA formation is well-docu-
mented [48,49]. However, the genetic basis for this predisposi-
tion is unknown. Although animal models may not perfectly reca-
pitulate human diseases, they can provide mechanistic insight 
toward understanding human pathology. The CaCl2-induced 
murine aneurysm model reproduces many features that have 
been clinically described in human AAA tissue, including mac-
rophage and T cell recruitment, MMP up-regulation, and elastin 
fragmentation. Studies have demonstrated that manipulation of 
MMP-2 and MMP- 9 levels have profound impacts on experimen-
tal aneurysm formation [7,8]. The current studies extend the pre-
vious work in demonstrating that even small differences in base-
line or stimulated expression of MMP-2 and MMP-9 affect aneu-
rysm size. Future studies examining factors regulating MMP 
gene expression will not only provide a greater understanding 
of the pathophysiology, but also may provide potential targets 
for therapeutic intervention. 
5. Conclusions 
A better understanding of genetic differences between patients 
with abdominal aortic aneurysms may help to identify causes 
of disease susceptibility and aneurysm growth rates. While it 
is known that abdominal aortic aneurysms run in families, a 
genetic linkage is currently unknown. This study helps to iden-
tify baseline MMP levels and aortic mechanical properties as 
potential factors that influence aortic aneurysm growth based 
on comparisons between 129/SvEv and C57Bl/6 mouse aortas 
before and after aneurysm induction. This work further extends 
the knowledge that small changes in MMP expression can dra-
matically affect aneurysm growth. The differences in arterial 
stiffness seen between the two mouse strains may help to explain 
why some patients have a predisposition to develop aortic aneu-
rysms or other vascular pathologies. 
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